Advertisement

Colgate-Palmolive Company CL

Set alert

Price alert · CL

All alert types
95.29 USD +2.13 +2.29%

At close · Oct 30

95.69 +0.40 +0.42%

After hours · Oct 30, 5:23 PM ET

Bid
95.27 × 300
Ask
95.37 × 100
94.83 Day range 98.38
74.98 52-week range 99.14
YTD
+20.59%
1 year
+24.55%
Open
98.00
Prev close
93.16
Mkt cap
75.96B
Vol
8.84M
Avg vol
4.80M
EPS
2.54
P/E
37.52
Div yield
2.28%
More statistics
Low
94.83
High
98.38
Forward P/E
23.50
Beta
0.32
Short ratio
3.19
Inst. own
86.55%
Dividend
2.12
Ex-div date
Oct 19, 2026
Earnings
Jan 29, 2027
50-d avg
89.44
200-d avg
89.63
1y target
98.15

5Y chart

Chart tools
Interval

Events in this range
  • Jan 21, 2022Dividend: 0.45
  • Apr 20, 2022Dividend: 0.47
  • Jul 20, 2022Dividend: 0.47
  • Oct 20, 2022Dividend: 0.47
  • Jan 20, 2023Dividend: 0.47
  • Apr 20, 2023Dividend: 0.48
  • Jul 20, 2023Dividend: 0.48
  • Oct 20, 2023Dividend: 0.48
  • Jan 19, 2024Dividend: 0.48
  • Jan 22, 2024Dividend: 0.48
  • Apr 19, 2024Dividend: 0.5
  • Jul 19, 2024Dividend: 0.5
  • Oct 18, 2024Dividend: 0.5
  • Jan 21, 2025Dividend: 0.5
  • Apr 17, 2025Dividend: 0.52
  • Jul 18, 2025Dividend: 0.52
  • Oct 17, 2025Dividend: 0.52
  • Oct 31, 2025Earnings: 0.91; estimate 0.889; surprise 2.36%
  • Jan 21, 2026Dividend: 0.52
  • Jan 30, 2026Earnings: 0.95; estimate 0.912; surprise 4.17%
  • Apr 20, 2026Dividend: 0.53
  • May 1, 2026Earnings: 0.97; estimate 0.943; surprise 2.86%
  • Jul 20, 2026Dividend: 0.53
  • Jul 31, 2026Earnings: 0.99; estimate 0.947; surprise 4.54%
  • Aug 3, 2026Rating: TD Cowen · Hold → Hold
  • Aug 3, 2026Rating: UBS · Buy → Buy
  • Sep 8, 2026Rating: RBC Capital · Outperform → Outperform
  • Sep 21, 2026Rating: Piper Sandler · Overweight → Overweight
  • Oct 5, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
  • Oct 19, 2026Rating: JP Morgan · Overweight → Overweight
  • Oct 20, 2026Dividend: 0.53
  • Oct 30, 2026Earnings: 0.97; estimate 0.926; surprise 4.75%
Signals (91)
NameDateAgo
MACD: Buy SignalOct 19, 20261 week ago
SMA: BullishOct 12, 20262 weeks ago
SMA: BullishOct 12, 20262 weeks ago
SMA: BearishAug 31, 20262 months ago
SMA: BearishAug 17, 20262 months ago
MACD: Sell SignalAug 17, 20262 months ago
SMA: BullishJul 27, 20263 months ago
SMA: BearishJul 20, 20263 months ago
MACD: Buy SignalMay 25, 20265 months ago
SMA: BullishMay 4, 20266 months ago
MACD: Sell SignalMar 30, 20267 months ago
SMA: BearishMar 9, 20267 months ago
RSI: OverboughtFeb 23, 20268 months ago
RSI: OverboughtFeb 2, 20269 months ago
SMA: BullishJan 12, 20269 months ago
SMA: BullishJan 5, 202610 months ago
SMA: BearishDec 29, 202510 months ago
SMA: BullishDec 22, 202510 months ago
SMA: BearishDec 1, 202511 months ago
SMA: BullishNov 17, 202511 months ago
MACD: Buy SignalNov 17, 202511 months ago
SMA: BearishJul 7, 20251 year ago
SMA: BearishJul 7, 20251 year ago
SMA: BullishJun 30, 20251 year ago
SMA: BullishJun 30, 20251 year ago
MACD: Sell SignalJun 16, 20251 year ago
SMA: BearishJun 2, 20251 year ago
SMA: BearishJun 2, 20251 year ago
SMA: BullishMay 19, 20251 year ago
SMA: BullishMay 19, 20251 year ago
SMA: BearishApr 28, 20251 year ago
SMA: BearishApr 28, 20251 year ago
SMA: BullishApr 7, 20251 year ago
SMA: BearishMar 10, 20251 year ago
SMA: BullishMar 3, 20251 year ago
MACD: Buy SignalMar 3, 20251 year ago
SMA: BullishFeb 17, 20251 year ago
SMA: BearishOct 21, 20242 years ago
MACD: Sell SignalSep 23, 20242 years ago
SMA: BearishSep 16, 20242 years ago
RSI: OverboughtJun 10, 20242 years ago
SMA: BullishApr 22, 20242 years ago
RSI: OverboughtApr 22, 20242 years ago
SMA: BearishApr 8, 20242 years ago
RSI: OverboughtFeb 19, 20242 years ago
RSI: OverboughtJan 29, 20242 years ago
SMA: BullishNov 13, 20232 years ago
MACD: Buy SignalNov 6, 20232 years ago
SMA: BullishOct 30, 20233 years ago
SMA: BearishOct 23, 20233 years ago
SMA: BullishOct 16, 20233 years ago
SMA: BearishAug 14, 20233 years ago
SMA: BearishAug 14, 20233 years ago
SMA: BullishAug 7, 20233 years ago
SMA: BullishJul 31, 20233 years ago
SMA: BearishJul 24, 20233 years ago
SMA: BearishJul 24, 20233 years ago
SMA: BullishJul 17, 20233 years ago
SMA: BullishJul 10, 20233 years ago
SMA: BearishJul 3, 20233 years ago
MACD: Sell SignalJul 3, 20233 years ago
SMA: BullishJun 12, 20233 years ago
SMA: BearishMay 29, 20233 years ago
SMA: BearishMay 22, 20233 years ago
MACD: Buy SignalApr 3, 20233 years ago
SMA: BullishMar 27, 20233 years ago
SMA: BullishMar 20, 20233 years ago
MACD: Sell SignalJan 23, 20233 years ago
SMA: BearishJan 16, 20233 years ago
SMA: BearishJan 16, 20233 years ago
SMA: BullishNov 21, 20223 years ago
MACD: Buy SignalNov 14, 20223 years ago
SMA: BullishNov 7, 20223 years ago
SMA: BearishOct 31, 20224 years ago
SMA: BullishOct 24, 20224 years ago
MACD: Sell SignalSep 12, 20224 years ago
SMA: BearishAug 29, 20224 years ago
SMA: BearishAug 22, 20224 years ago
SMA: BullishJul 25, 20224 years ago
SMA: BullishJul 25, 20224 years ago
SMA: BearishJul 18, 20224 years ago
SMA: BearishJul 4, 20224 years ago
SMA: BullishJun 20, 20224 years ago
SMA: BullishJun 20, 20224 years ago
SMA: BearishJun 6, 20224 years ago
SMA: BullishMay 23, 20224 years ago
SMA: BearishMay 16, 20224 years ago
SMA: BullishMay 9, 20224 years ago
SMA: BearishApr 25, 20224 years ago
SMA: BullishApr 4, 20224 years ago
SMA: BearishJan 31, 20224 years ago

Key statistics

Market cap
76.56B
Enterprise value
81.00B
Trailing P/E
37.81
Forward P/E
23.50
PEG ratio
1.70
Price / sales
3.64
Price / book
324.48
EPS (TTM)
2.54
Beta
0.32
Dividend yield
2.28%
Payout ratio
82.28%
Profit margin
9.68%
Revenue (TTM)
21.05B
Revenue growth
4.90%
Free cash flow
3.46B
Total cash
1.45B
Total debt
7.86B
Return on equity
267.37%
Shares outstanding
797.17M
Short % of float
2.44%
50-day average
89.44
200-day average
89.63

Analyst view

Consensus: buy

Buy
Price target (mean) 98.15 +3.0% upside
Target (low)
87.00
Target (mean)
98.15
Target (high)
110.00
Ratings (0m) 21 13 buy · 7 hold · 1 sell
  • Strong buy6
  • Buy7
  • Hold7
  • Sell0
  • Strong sell1

Next earnings

Jan 29, 2027

Expected Jan 29, 2027. Consensus EPS estimate 0.9634.

Earnings history

Financials — quick view

All financials
CL Revenue — quarterly 5.37B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
CL Net income — quarterly 751.00M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
CL EPS — quarterly 0.94
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

CL recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Jan 29, 2027Dec 30, 20260.97———
Oct 30, 2026Sep 30, 20260.9260.97+0.04+4.75%
Jul 31, 2026Jun 30, 20260.9470.99+0.04+4.54%
May 1, 2026Mar 31, 20260.9430.97+0.03+2.86%
Jan 30, 2026Dec 31, 20250.9120.95+0.04+4.17%
Oct 31, 2025Sep 30, 20250.8890.91+0.02+2.36%

Upgrades / downgrades

CL analyst upgrades and downgrades
DateFirmActionFromTo
Oct 19, 2026JP MorganmainOverweightOverweight
Oct 5, 2026Wells FargomainEqual-WeightEqual-Weight
Sep 21, 2026Piper SandlermainOverweightOverweight
Sep 8, 2026RBC CapitalreitOutperformOutperform
Aug 3, 2026UBSmainBuyBuy
Aug 3, 2026TD CowenmainHoldHold

About Colgate-Palmolive Company

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Sector
Consumer Defensive
Industry
Household & Personal Products
Country
United States

News

Your note

Sign in to keep a note on CL — it syncs with the Stock Master app.

Insider holders

CL insider holders
InsiderRelationLatest transactionDateShares held
BILBREY JOHN P.DirectorStock Award(Grant)Jun 30, 202644,948
CAHILL JOHN TDirectorConversion of Exercise of derivative securityAug 5, 202664,730
DANIELS JENNIFER M.OfficerStock Award(Grant)Feb 22, 202691,681
GRANT SHANEOfficerStock Award(Grant)Sep 10, 202594,119
HAZLIN JOHNOfficerStock Award(Grant)Feb 22, 202629,874
NORRINGTON LORRIE MDirectorStock Award(Grant)Jun 30, 202642,769

Institution ownership

CL institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.77%69,915,4726.72BJun 29, 2026
Vanguard Capital Management LLC6.55%52,246,3335.02BJun 29, 2026
State Street Corporation5.90%47,020,9664.52BJun 29, 2026
Price (T.Rowe) Associates Inc3.50%27,909,5252.68BJun 29, 2026
Vanguard Portfolio Management LLC3.01%24,021,1372.31BJun 29, 2026
Geode Capital Management, LLC2.90%23,144,3192.22BJun 29, 2026

Fund ownership

CL fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.19%25,400,4662.44BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.60%20,732,7881.99BJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.33%10,622,0611.02BSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.30%10,387,165997.64MAug 30, 2026
SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust1.24%9,863,196947.31MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Value Index Fund0.95%7,610,832730.98MJun 29, 2026
Advertisement